[Incomplete antibodies in infections diseases]. 1958

C VAN MARWYCK

UI MeSH Term Description Entries
D003141 Communicable Diseases An illness caused by an infectious agent or its toxins that occurs through the direct or indirect transmission of the infectious agent or its products from an infected individual or via an animal, vector or the inanimate environment to a susceptible animal or human host. Infectious Diseases,Communicable Disease,Disease, Communicable,Disease, Infectious,Diseases, Communicable,Diseases, Infectious,Infectious Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D019138 Antibodies, Blocking Antibodies that inhibit the reaction between ANTIGEN and other antibodies or sensitized T-LYMPHOCYTES (e.g., antibodies of the IMMUNOGLOBULIN G class that compete with IGE antibodies for antigen, thereby blocking an allergic response). Blocking antibodies that bind tumors and prevent destruction of tumor cells by CYTOTOXIC T-LYMPHOCYTES have also been called enhancing antibodies. (Rosen et al., Dictionary of Immunology, 1989) Antibodies, Enhancing,Blocking Antibodies,Enhancing Antibodies

Related Publications

C VAN MARWYCK
April 1959, Zeitschrift fur Immunitatsforschung und experimentelle Therapie,
C VAN MARWYCK
January 1967, Bulletin de l'Academie polonaise des sciences. Serie des sciences biologiques,
C VAN MARWYCK
April 1973, Deutsche medizinische Wochenschrift (1946),
C VAN MARWYCK
January 1967, Microbiologia, parazitologia, epidemiologia,
C VAN MARWYCK
August 1969, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
C VAN MARWYCK
November 1966, Nature,
C VAN MARWYCK
January 1958, Bibliotheca haematologica,
C VAN MARWYCK
December 1970, Giornale di malattie infettive e parassitarie,
C VAN MARWYCK
November 2001, The New England journal of medicine,
Copied contents to your clipboard!